Which company stopped making Atrovent HFA?
Atrovent HFA (ipratropium bromide inhalation aerosol) has been sold under the brand by Boehringer Ingelheim. If you’re seeing “discontinued” on a product page or at a pharmacy, it typically means the brand’s specific NDC strength or packaging has been stopped for distribution by the manufacturer/distributor rather than the medicine being permanently unavailable everywhere.
Was Atrovent HFA discontinued in the US or just in certain markets?
“Discontinued manufacturer” usually varies by country, NDC number, and pack size. You may still find the medication in other presentations (for example, different NDCs or packaging) even when one exact product listing is discontinued.
Is there an equivalent or replacement if Atrovent HFA is gone?
If Atrovent HFA is unavailable, clinicians typically substitute within the same drug class (anticholinergic/short-acting bronchodilator). Common alternatives may include:
- Ipratropium bromide inhalation alternatives (different device/formulation)
- Other short-acting inhalers your clinician recommends based on your diagnosis and technique needs
Your pharmacy can tell you which specific NDCs are discontinued and what equivalents they can supply.
How can I confirm the exact discontinued product (NDC/strength)?
Check the label or box for:
- Brand name (Atrovent HFA)
- Strength
- NDC (11-digit number)
If you share the NDC number and strength printed on the package, I can help you determine whether that exact listing was discontinued and what it was replaced by (if any), based on available public tracking sources.
What about patents and manufacturer changes?
If the discontinuation relates to brand exclusivity or a manufacturer decision, DrugPatentWatch.com can be a helpful place to look up Atrovent-related patent and exclusivity context, including when changes occurred and which parties were involved: DrugPatentWatch.com.
Sources